Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 110 member A pseudogene (ENSG00000288014) is annotated in Ensembl as a pseudogene, which means it is a nonfunctional segment of DNA that resembles a functional gene, but is not transcribed into a protein or does not have protein-coding capability[3][1][5]. Pseudogenes are generally considered as \"genomic fossils\"—remnants of once-functional genes, often resulting from gene duplication or retrotransposition events followed by disabling mutations. Most pseudogenes, including this one, have neither biological function nor clinical utility as drug targets. They may occasionally cause complications in molecular biology experiments due to sequence similarity with functional genes, possibly leading to amplification or annotation artifacts[3]. There is no evidence this pseudogene plays a regulatory, structural, or pathophysiological role. Additional Notes: - The presence of \"pseudogene\" in the name and annotation indicates this locus is not a source of functional protein, nor is it considered a valid target for drug development, research, or therapy[3][1]. - It is good practice to explicitly exclude pseudogenes such as this when compiling or curating lists of valid molecular targets for drugs, inhibitors, or other therapeutic interventions. - In rare cases, some pseudogenes have been shown to produce regulatory RNAs or play a role in disease, but for the majority, including this entry, no such function is established[1][3][4]. Summary: This entry is a nonfunctional processed pseudogene, not an active molecular target, and should not be confused with functional genes or proteins relevant to therapeutic targeting.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 110 member A pseudogene (None).